The basics of bioidentical hormone replacement therapy. Available at www.oprah.com/health/the-basics-of-bioidentical-hormone-replacement-therapy Accessed July16, 2014.
2.
SomersS. Bioidentical hormones and wellness. Available at www.suzannesomers.com/pages/forever-health Accessed July16, 2014.
3.
CiriglianoM. Bioidentical hormone therapy: A review of the evidence. J Womens Health., 2007; 16:600–631.
SitesCK. Bioidentical hormones for menopausal therapy. Womens Health (Lond Engl), 2008; 4:163–171.
6.
BhavnaniBR, StanczykFZ. Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. J Clin Endocrinol Metab., 2012; 97:756–759.
7.
GlavinM. Letter from M. Glavin regarding Wyeth citizen petition. Available at www.fda.gov/ohrms/dockets/dockets/05p0411/BHRTletter.html Accessed July16, 2014.
8.
CruseAE. FDA warning letter, Reed's Compounding Pharmacy. 2008. Available at www.fda.gov/iceci/enforcementactions/warningletters/2008/ucm1048446 htm Accessed July14, 2014.
9.
FDA Consumer Health Information. Bio-identicals: Sorting myths from facts. 2013. Available at www. fda.gov/forconsumers/consumerupdates/ucm049311.htm. Accessed July16, 2014.
10.
DavisR, BaturP, ThackerH. Risks and effectiveness of compounded bioidentical hormone therapy: A case series of patient experiences. J Womens Health, 2014; 23:642–648.
11.
2006 Limited FDA survey of compounded drug products. Available at www.fda.gov/drugs/guidancecomplianceregulatoryinformation/pharmacycompounding/ucm204237.htm Accessed April14, 2014.
12.
Committee on Gynecologic Practice and the American Society for Reproductive Medicine Practice Committee. Committee opinion No. 532: Compounded bioidentical menopausal hormone therapy. Obstet Gynecol, 2012; 120:411–415.
13.
US Food and Drug Administration. Compounding: Inspections, recalls, and other actions. Updated June11, 2014. Available at www.fda.gov/drugs/guidancecomplianceregulatoryinformation/pharmacycompounding/ucm339771.htm Accessed July17, 2014.
14.
Guidance: Pharmacy compounding of human drug products under section 503 A of the Federal Food, Drug, and Cosmetic Act. Available at fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm377052.pdf Accessed July16, 2014.
15.
Pharmacy compounding of human drug products under Section 503A of the Federal Food, Drug, and Cosmetic Act Available at www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm377052.pdf Accessed 7-16-14
16.
North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause., 2012; 19:257–271.
17.
The Endocrine Society position statement. Bioidentical hormones. 2006. Available at www.endocrine.org/∼/media/endosociety/files/advocacy%20and%20outreach/position%20statements/all/bh_position_statement_final_10_25_06_w_header pdf Accessed July16, 2014.
